A80G polymorphism of reduced folate carrier 1 (RFC1) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down’s syndrome etiology
Keywords:
Down syndrome, Polymorphism, genetic, Folic acid, Nondisjunction, genetic, TranscobalaminsAbstract
CONTEXT AND OBJECTIVE: There is evidence that polymorphisms of genes involved in folate metabolism may be associated with higher risk that mothers may bear a Down’s syndrome (DS) child. This study therefore had the objective of investigating the A80G polymorphism of the reduced folate carrier 1 (RFC1) gene and the C776G polymorphism of the transcobalamin 2 (TC2) gene as maternal risk factors for DS among Brazilian women. DESIGN AND SETTING: Analytical cross-sectional study with control group, at Faculdade de Medicina de São José do Rio Preto (Famerp). METHODS: Sixty-seven mothers of DS individuals with free trisomy 21, and 113 control mothers, were studied. Molecular analysis of the polymorphisms was performed by means of the polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP), followed by electrophoresis on 2% agarose gel. RESULTS: The frequencies of the polymorphic alleles were 0.51 and 0.52 for RFC1 80G, and 0.34 and 0.34 for TC2 776G, in the case and control groups, respectively. Thus, there were no differences between the groups in relation to either the allele or the genotype frequency, for both polymorphisms (P = 0.696 for RFC1 A80G; P = 0.166 for TC2 C776G; P = 0.268 for combined genotypes). CONCLUSION: There was no evidence of any association between the RFC1 A80G and TC2 C776G polymorphisms and the maternal risk of DS in the sample evaluated.
Downloads
References
Oliver TR, Feingold E, Yu K, et al. New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet. 2008;14;4(3):e1000033.
Jyothy A, Kumar KS, Mallikarjuna GN, et al. Parental age and the origin of extra chromosome 21 in Down syndrome. J Hum Genet. 2001;46(6):347-50.
Gusmão FA, Tavares EJ, Moreira LM. Idade materna e sín- drome de Down no Nordeste do Brasil. [Maternal age and Down syndrome in Northeast Brazil]. Cad Saude Publica. 2003;19(4):973-8.
Beiguelman B, Krieger H, Silva LM. Maternal age and Down syndrome in Southeastern Brazil. Rev Bras Genet = Braz J Genet. 1996;19(4):637-40.
Fenech M. Micronutrients and genomic stability: a new para- digm for recommended dietary allowances (RDAs). Food Chem Toxicol. 2002;40(8):1113-7.
Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol. 2000;32(4):385-9.
D’Alessio AC, Szyf M. Epigenetic tête-à-tête: the bilateral rela- tionship between chromatin modifications and DNA methyla- tion. Biochem Cell Biol. 2006;84(4):463-76.
Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic- induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis. 2004;25(3):413-7.
Biselli JM, Goloni-Bertollo EM, Zampieri BL, Haddad R, Eberlin MN, Pavarino-Bertelli EC. Genetic polymorphisms involved in folate metabolism and elevated plasma concentra- tions of homocysteine: maternal risk factors for Down syndrome in Brazil. Genet Mol Res. 2008;7(1):33-42.
Coppedè F, Marini G, Bargagna S, et al. Folate gene polymor- phisms and the risk of Down syndrome pregnancies in young Italian women. Am J Med Genet A. 2006;140(10):1083-91.
da Silva LR, Vergani N, Galdieri L de C, et al. Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet A. 2005;135(3):263-7.
Acácio GL, Barini R, Bertuzzo CS, Couto EC, Annichino- Bizzacchi JM, Júnior WP. Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21. Prenat Diagn. 2005;25(13):1196-9.
Fillon-Emery N, Chango A, Mircher C, et al. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr. 2004;80(6):1551-7.
Chango A, Emery-Fillon N, de Courey GP, et al. A polymor- phism (80G-A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab. 2000;70(4):310-5.
Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology. 1997;112(3):783-91.
Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R. Transcobalamin II 775GC polymorphism and indices of vita- min B12 status in healthy older adults. Blood. 2002;100(2):718- 20.
Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet. 2002;10(7):433-8.
Yamada K, Gravel RA, Toraya T, Matthews RG. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci U S A. 2006;103(25):9476-81.
Miller SA, Dykes DD, Polesky HF. A simple salting out proce- dure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Födinger M, Dierkes J, Skoupy S, et al. Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol. 2003;14(5):1314-9.
Pietrzyk JJ, Bik-Multanowski M. 776CG polymorphism of the transcobalamin II gene as a risk factor for spina bifida. Mol Genet Metab. 2003;80(3):364.
Coelho IS. Doenças cromossômicas. Available from: http://www. ufv.br/dbg/BIO240/DC14.htm. Accessed in 2008 (Sep 10).
Barros ACSD, Zugaib M, Pereira PP, Guglielmi GF, Durante AA. Gestantes de pelo menos 45 anos de idade: considerações sobre 40 casos. [Pregnant women of 45 or more. Considerations on 40 cases]. J Bras Ginecol. 1984;94(1/2):33-6.
Hansen JP. Older maternal age and pregnancy outcome: a review of the literature. Obstet Gynecol Surv. 1986;41(11):726-42.
Kiely JL, Paneth N, Susser M. An assessment of the effects of maternal age and parity in different components of perinatal mortality. Am J Epidemiol. 1986;123(3):444-54.
Schupp T. Espaço médico: idade materna avançada. Avail- able from: http://drauziovarella.ig.com.br/espaco/espaco. asp?doe_id=25. Accessed in 2008 (Sep 10).
Castilla EE, Lopez-Camelo JS, Paz JE. Atlas geográfico de las malformaciones congénitas en sudamérica. Rio de Janeiro: Fiocruz; 1995.
Eskes TK. Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):130-3.
James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999;70(4):495-501.
Chango A, Fillon-Emery N, Mircher C, et al. No association between common polymorphisms in genes of folate and homo- cysteine metabolism and the risk of Down’s syndrome among French mothers. Br J Nutr. 2005;94(2):166-9.
Whetstine JR, Gifford AJ, Witt T, et al. Single nucleotide poly- morphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7(11):3416-22.
Guéant-Rodriguez RM, Rendeli C, Namour B, et al. Transco- balamin and methionine synthase reductase mutated polymor- phisms aggravate the risk of neural tube defects in humans. Neurosci Lett. 2003;344(3):189-92.
Barkai G, Arbuzova S, Berkenstadt M, Heifetz S, Cuckle H. Frequency of Down’s syndrome and neural-tube defects in the same family. Lancet. 2003;361(9366):1331-5.
Guéant JL, Guéant-Rodriguez RM, Anello G, et al. Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med. 2003;41(11):1473-7.
De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural- tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135-42.
Pitkin RM. Folate and neural tube defects. Am J Clin Nutr. 2007;85(1):285S-288S.
